You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
A randomized, double-blind, placebo-controlled crossover study of α4β2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder
|
|---|---|
| Published in |
Psychopharmacology, May 2013
|
| DOI | 10.1007/s00213-013-3116-7 |
| Pubmed ID | |
| Authors |
Aurelija Jucaite, John Öhd, Alexandra S. Potter, Judith Jaeger, Pär Karlsson, Kristin Hannesdottir, Emma Boström, Paul A. Newhouse, Björn Paulsson |
| Abstract |
Stimulation of nicotinic cholinergic systems has been shown to alleviate ADHD symptoms and to improve cognitive performance. AZD1446 is a selective α4β2* nicotinic acetylcholine receptor agonist with potential effect on the symptoms of ADHD. |
Mendeley readers
The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| France | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 140 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 22 | 15% |
| Student > Bachelor | 22 | 15% |
| Researcher | 17 | 12% |
| Student > Master | 16 | 11% |
| Student > Doctoral Student | 8 | 6% |
| Other | 31 | 22% |
| Unknown | 27 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 48 | 34% |
| Medicine and Dentistry | 15 | 10% |
| Neuroscience | 9 | 6% |
| Unspecified | 7 | 5% |
| Agricultural and Biological Sciences | 5 | 3% |
| Other | 25 | 17% |
| Unknown | 34 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2019.
All research outputs
#8,647,454
of 25,654,806 outputs
Outputs from Psychopharmacology
#2,243
of 5,352 outputs
Outputs of similar age
#71,130
of 205,017 outputs
Outputs of similar age from Psychopharmacology
#33
of 60 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,352 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 205,017 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.